Young people aged 15–24 years account for a third of people with HIV in sub-Saharan Africa and a third of new infections worldwide. HIV testing among this population remains disproportionately low compared with adults, with coverage even lower among adolescents aged 15–19 years. Late HIV diagnosis, delays in antiretroviral therapy initiation and poor adherence to treatment have resulted in poor clinical outcomes among this age group.